SFI
DXCM icon

Susquehanna Fundamental Investments’s DexCom DXCM Stock Holding History

Susquehanna Fundamental Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-104,081
Closed -$9.09M – 618
2025
Q2 		$9.09M Sell
104,081
-59,011
-36% -$4.63M 0.24% 119
2025
Q1 		$11.1M Sell
163,092
-139,366
-46% -$11.4M 0.16% 164
2024
Q4 		$23.5M Buy
+302,458
New +$22.4M 0.34% 59
2024
Q2 		$3.73M Buy
+32,881
New +$4.16M 0.09% 281
2021
Q2 		– Sell
-141,548
Closed -$12.7M – 1680
2021
Q1 		$12.7M Sell
141,548
-45,756
-24% -$4.3M 0.22% 113
2020
Q4 		$17.3M Buy
+187,304
New +$16.7M 0.32% 66

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna Fundamental Investments's DXCM Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of DexCom (DXCM) in Q3 2025, closing a stake of 104,081 shares — an estimated $9.09M sold.

Susquehanna Fundamental Investments first reported a position in DXCM in Q4 2020 and held it in 6 quarters. The position peaked at $23.5M in Q4 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Susquehanna Fundamental Investments reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 104,081 DexCom shares in Q3 2025, an estimated $9.09M.
  • Susquehanna Fundamental Investments first reported a position in DexCom in Q4 2020 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's DexCom position peaked at $23.5M in Q4 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.